FDA
-
-
-
-
-
-
-
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
-
-
-
-
-
-
-
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
IRADIMED Names John F. Glenn Chief Financial Officer
-
-
-
-
-
-
-
IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results
-
-
-
-
-
-
-
IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

